CYTK vs SOFI · rev $28.6M vs P/E 39, rev $283.1M
Cytokinetics Inc (CYTK) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
Latest reported SOFI revenue for 2026-06-30 was $283.1M. Net income was $323.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
CYTK currently screens at market cap $4.05B. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the CYTK and SOFI stock pages for the full models.
Not investment advice.